F2 and Thrombocytopenia: Earlier studies from China reported elevated D-dimers, a fibrin degradation product indicating thrombosis, in 46 to 63% of patients along with thrombocytopenia and prolonged prothrombin time associated with worse clinical outcomes [6,7].